Bryan Johnson’s ongoing relationship with girlfriend and Blueprint co-founder Kate Tolo remains the central driver of trader sentiment on whether he will publicly confirm sexual activity by the resolution date. Recent August 2026 posts and a New York Post interview detail their nearly four-year arrangement of separate beds and homes, chosen to protect his optimized sleep scores and biological-age metrics under the $2-million Blueprint protocol. Johnson has stated that intimacy occurs in bed while framing sexual function as a measurable longevity input, with earlier 2026 disclosures on post-intimacy biomarkers such as prolactin and oxytocin. Upcoming catalysts include any new X updates on relationship status, health logs, or protocol adjustments before the cutoff, as resolution hinges solely on his public announcements rather than private behavior.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedAugust 31
51%
September 30
52%
$4,348 Vol.
August 31
51%
September 30
52%
The primary resolution source for this market will be official information from Bryan Johnson, including through his official X account (https://x.com/bryan_johnson).
Market Opened: Jul 29, 2026, 3:50 PM ET
Resolver
0x65070BE91...The primary resolution source for this market will be official information from Bryan Johnson, including through his official X account (https://x.com/bryan_johnson).
Resolver
0x65070BE91...Bryan Johnson’s ongoing relationship with girlfriend and Blueprint co-founder Kate Tolo remains the central driver of trader sentiment on whether he will publicly confirm sexual activity by the resolution date. Recent August 2026 posts and a New York Post interview detail their nearly four-year arrangement of separate beds and homes, chosen to protect his optimized sleep scores and biological-age metrics under the $2-million Blueprint protocol. Johnson has stated that intimacy occurs in bed while framing sexual function as a measurable longevity input, with earlier 2026 disclosures on post-intimacy biomarkers such as prolactin and oxytocin. Upcoming catalysts include any new X updates on relationship status, health logs, or protocol adjustments before the cutoff, as resolution hinges solely on his public announcements rather than private behavior.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions